ASTIKI MI KERDOSKOPIKI ETAIREIA PROLIPTIKIS PERIVALLONTIKIS KAI ERGASIAKIS IATRIKIS

Their core work

Institouto Prolepsis is a Greek non-profit institute specializing in preventive medicine and public health, with a strong focus on reaching underserved and marginalized populations. They design and implement tailored health interventions — from vaccination programs for children and adolescents in hard-to-reach communities to cancer screening initiatives for homeless people across Europe. Their work combines participatory action research with practical, community-level health delivery, bridging the gap between health policy and the people most often left out of it.

What they specialise in

How they've shifted over time

Their earliest H2020 work (INHERIT, 2016) explored broad environment-health connections — a wide-angle preventive medicine lens without a specific target population. From 2021 onward, the focus sharpened dramatically toward health equity for specific marginalized groups: underserved communities lacking vaccine access, and homeless populations excluded from cancer screening. The trajectory shows a clear pivot from general preventive health research to targeted, equity-driven interventions for Europe's most vulnerable.

Prolepsis is moving decisively toward health interventions for hard-to-reach populations — expect future work on vaccination equity, disease prevention among homeless or migrant communities, and participatory health system design.

How they like to work

Prolepsis operates exclusively as a consortium participant, never as coordinator, which is typical for specialized NGOs that contribute domain expertise rather than managing large multi-partner projects. With 41 unique partners across 17 countries from just 3 projects, they work in large European consortia and bring a specific skill set — community engagement, field research with marginalized groups — rather than leading the administrative effort. This makes them a reliable, low-friction partner for coordinators who need genuine field-level access to underserved populations.

Despite only 3 projects, Prolepsis has collaborated with 41 different partners across 17 countries, indicating participation in large, geographically diverse EU health consortia. Their network spans a broad European reach rather than clustering around a single region.

What sets them apart

What sets Prolepsis apart is their combination of NGO fieldwork credibility with rigorous health research — they are not a university publishing papers, nor a service provider delivering healthcare, but an institute that designs and tests interventions directly with the communities that need them. Their niche in reaching populations that formal health systems consistently miss (homeless, unvaccinated children in marginalized communities) is rare and increasingly valuable as EU health policy shifts toward equity. For consortium builders, they offer something hard to find: genuine access to and trust within underserved communities across Southern and Eastern Europe.

Highlights from their portfolio

• RIVER-EU
  Their largest funded project (EUR 313K), running until 2026, tackling the politically and socially important issue of vaccine hesitancy and inequality for MMR/HPV among Europe's underserved children.
• CANCERLESS
  Addresses the almost entirely overlooked problem of cancer prevention among homeless populations — an unusual and high-impact research target that few organizations in Europe work on.